Home Companies Cancer Genetics

Cancer Genetics

Latest
Cancer Genetics

Interpace Diagnostics Buys Cancer Genetics’ BioPharma Business for $23.5M

Cancer Genetics (CGI) has terminated its planned merger with NovellusDx and will instead “pursue alternative strategic and financial transactions” intended to enhance shareholder value.. [nicolas_ / Getty Imagesnicolas_ / Getty Images]
Cancer Genetics

Cancer Genetics Scraps Planned Merger with NovellusDx

Panna Sharma has stepped down as CEO at Cancer Genetics Inc.
Cancer Genetics

Cancer Genetics CEO Panna Sharma Steps Down

Cancer Genetics (CGI) has received $1.1 million in net cash proceeds through the transfer of tax credits approved by the New Jersey Technology Business Tax Certificate Transfer (NOL) program of the New Jersey Economic Development Authority (NJEDA). [Source: Maxim_Kazmin/Fotolia]
Cancer Genetics

Cancer Genetics Gains $1.1M from NJ Net Operating Loss Program

Source: Filograph/Getty Images
Cancer Genetics

Third Quarter Brings Record Revenue for Cancer Genetics

Source: © freshidea/Fotolia
Cancer Genetics

Cancer Genetics to Offer Biomarker Services for eFFECTOR Therapeutics Lead Candidate

Source: Vitanovsky/Fotolia
Cancer Genetics

Ignyta to Use Angsana Cancer Panel in Registrational Trial of Anti-Tumor...

Source: AlexRaths/Getty Images
Cancer Genetics

Philips Expands Personalized Cancer Collaboration with NYMC

Source: Tempus
Cancer Genetics

University of Michigan Taps Tempus to Commercialize MI-ONCOSEQ Cancer Panel

Source: xrender/Getty Images
Cancer Genetics

Sanford Health Enrolling Patients for Genomic Profiling Research

Load more

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up